Ann: Investor Presentation, page-26

First 26 Last

Share
Profile

Follow
JayWin

3,563 Posts.

413

18/09/19

22:13

Post #: 40473659
Share

Originally posted by gSek: ↑

All these people talkng about cash burn and having to do a CR again in 3 - 6 months are forgetting that the company grew ARR by 167%. Actual realised revenue grew by 244% over the FY. Topline growth is growing faster than expenses or cash out flow and if this strong growth continues, the company should be generating positive operating cash flow in about 2 years time. I would be surprised if employee and contracter expenses doubled or trippled again next year - this was the company's biggest expense. Secondly, there would be a good reason why the company increased its employment expense because it is growing fast and needs more employees to service a growing customer base, product development and innovation etc. etc. A large chunk of the expenses were contracters; contracters are not full time employees and it maybe possible to see this cost reduce once they are no longer needed or their contracts expire. The CR sucks but perhaps management (based on their forecasts) feels that this amount would be sufficient to support the business until it is operationally supporting itself. Founders own 30% of the company, I'm sure their interests are aligned with shareholders and want to see this company succeed.

Expand

Excellent summary.

I don't think we will see much activity below 35c, maybe some overhang and we'll be on our way up in a north easterly direction

LVT Price at posting: 40.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CC9

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

FFM

Firefly positioned for copper growth in Canada ahead of resource update

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 10 more messages in this thread...

First 26 Last

Add LVT (ASX) to my watchlist

Ann: Investor Presentation, page-26

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Firefly positioned for copper growth in Canada ahead of resource update

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News